LabCorp
LH
#1114
Rank
NZ$35.77 B
Marketcap
NZ$436.31
Share price
2.06%
Change (1 day)
4.16%
Change (1 year)
Laboratory Corporation of America Holdings or LabCorp is a US company that offers clinical laboratory services. The company supplies laboratory results for the diagnosis of diseases and the development of new drugs.

EPS for LabCorp (LH)

EPS in 2026 (TTM): NZ$19.40

According to LabCorp's latest financial reports the company's current EPS (TTM) is NZ$19.39. In 2025 the company made an earnings per share (EPS) of NZ$17.98 an increase over its 2024 EPS that were of NZ$15.18.

EPS history for LabCorp from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$19.407.94%
2025NZ$17.9818.45%
2024NZ$15.1889.15%
2023NZ$8.02-66.26%
2022NZ$23.78-43.33%
2021NZ$41.9654.11%
2020NZ$27.2389.43%
2019NZ$14.37-3.33%
2018NZ$14.87-29.7%
2017NZ$21.1575.74%
2016NZ$12.0463.19%
2015NZ$7.38-28.4%
2014NZ$10.30-6.13%
2013NZ$10.975.2%
2012NZ$10.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
IDEXX Laboratories
IDXX
NZ$23.39 20.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$15.66-19.28%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.06-105.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.52-81.87%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
NZ-$0.36-101.85%๐Ÿ‡บ๐Ÿ‡ธ USA